Quick Answer
Pasithea Therapeutics Corp. reported Stockholders Equity of $55.22 million for fiscal year 2025.
Pasithea Therapeutics Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $55.22M | +273.5% |
| 2024 | $14.78M | -36.8% |
| 2023 | $23.40M | -44.9% |
| 2022 | $42.50M | -17.4% |
| 2021 | $51.42M | +21204.9% |
| 2020 | $241.4K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.21M | -31.5% | -19.6% |
| June 30, 2025 | $15.18M | -6.2% | +16.9% |
| March 31, 2025 | $12.98M | -34.7% | -12.2% |
| December 31, 2024 | $14.78M | -36.8% | -17.0% |
| September 30, 2024 | $17.81M | -37.2% | +10.1% |
| June 30, 2024 | $16.18M | -54.6% | -18.6% |
| March 31, 2024 | $19.88M | -49.2% | -15.0% |
| December 31, 2023 | $23.40M | -44.9% | -17.5% |
- Pasithea Therapeutics Corp. showed an increase of +273.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Pasithea Therapeutics Corp.’s stockholders equity has grown by 22778.8% (from $241.4 thousand to $55.22 million).
- The most recent figure is from Pasithea Therapeutics Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: